As HIV testing technology advances, we have new tools and guidelines to diagnose HIV. For the latest updates from the CDC and APHL about conventional and point of care testing visit the Essential Resources page.
APLA-Shared ActionHD produced the webinar“HIV Testing Technologies: Choosing an HIV Test,” presented by Dr. Bernard M. Branson, a leading expert in the area of HIV testing. The webinar described general principles of HIV tests, provided an overview of how tests operate, addressed any limitations and misconceptions of HIV tests currently available, and discussed how the various tests differ.
CDC’s MMWR and Medscape are proud to introduce a new FREE continuing education (CE) activity that describes diagnosis delays among persons infected with HIV: Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays — United States. This activity is intended for infectious disease clinicians, family medicine specialists, internists, nurses, pharmacists, public health officials, and other clinicians caring for patients with or at risk for HIV infection.
The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment.
After a year of repeal and replace efforts in Congress, enrollees and community advocates are preparing for the 2018 health care open enrollment period. With substantially higher premiums, health plan exits, uncertainty around subsidies, shorter enrollment periods, and less money being spent on advertising, 2018 is projected to present new barriers to ensuring access to healthcare.
This activity is intended for primary care physicians, ID/HIV specialists, and public health and preventive medicine specialists.
The goal of this activity is to improve recognition among primary care providers of patients who could benefit from human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) medications.
DSHS encourages Texas healthcare providers to enhance efforts to prevent, diagnose and treat HIV in the wake of 16 rapidly growing clusters of HIV infections in the state.
Pre-exposure prophylaxis regimens containing Selzentry were generally safe and well-tolerated compared with Truvada, the standard-of-care PrEP drug, according to the results of a phase 2 trial.
The DSHS HIV/STD Prevention and Care Branch announces this Request for Application (RFA) to provide sustainable, integrated, routine, opt-out screening for HIV in healthcare settings in hospital systems emergency services and primary care in community health centers that serve under- and uninsured populations in high morbidity areas in Texas.
According to a new modeling study, HIV incidence could be reduced by one third if almost half of eligible men who have sex with men participated in PrEP. Treatment adherence is an important aspect in the model. Targeting individuals at a substantial risk for transmission is also key.
The need for new options in PrEP that are cost-effective and efficacious is driving innovation in the field of nanotechnology.
Clinical Conversations is a free CME teleconference, which includes four 30-minute, personalized, peer-to-peer conversations with nationally renowned experts on the implementation of PrEP as an HIV-prevention strategy in healthcare settings.
Join Treatment Action Group and the HIV Prevention Justice Alliance for a webinar on July 11, 12:30 – 2 p.m. CT, that will explore different forms of stigma that continue to pose a significant barrier to accessing comprehensive HIV prevention services
This module covers the impact of stigma on transgender individuals in healthcare settings. The module also will equip attendees to effectively engage transgender individuals who seek care.
The Journal of the Association of Nurses in AIDS Care (JANAC) plans to publish a special issue on the topic of Mental Health & Substance Use Issues in HIV Infection in early 2017.
Presentations from the 2016 Test Texas HIV Coalition Summit held in Austin on May 12-13, 2016 Thursday, May 12 Evaluation and Integration: Essential Components for Successful ED HIV Testing Programs (Gardner, Moore) (PDF) Linkage to Care Models (Clark) (PDF) Quality Improvement: Quality Management Core Tool Instructions (Clark) (PDF) Friday, May 13 State of the State … Continue reading 2016 Test Texas HIV Coalition Summit Presentations
The 2016 Test Texas HIV Coalition Summit took place in Austin on May 12-13. View the Summit program (PDF).
More than 1.2 million people in the United States are living with HIV — and one in eight of them don’t know they have the infection, according to the Department of Health and Human Services. In Phoenix, one hospital is trying to find those people, diagnose them — and get them into treatment.
The Texas Department of State Health Services will host the 2016 Texas HIV/STD Conference on October 4-6, 2016 at the Renaissance Hotel in Austin, Texas. The theme of the conference is Empowering Transformations – A New Generation of HIV/STD PrEPardedness, Prevention and Care. This biennial event is designed for HIV/STD health professionals who serve Texans … Continue reading 2016 Texas HIV/STD Conference Update
Sponsored by The Well Project and The Women’s Collective Tuesday, May 10 12:00–1:30 pm ET This webinar will provide an overview PrEP for women, with a specific focus on women of color, through a multi-disciplinary approach. HIV and HIV Prevention Among US Women: A Role for PrEP – Charlene Flash, MD, MPH, Baylor College of … Continue reading PrEP in Practice: Considerations for HIV Prevention among Women of Color